By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Hataasia 5 Street
P.O. Box 6
Migdal HaEmeq    23106  Israel
Phone: 972-4-654-5112 Fax: 972-4-644-3799



Company News
Enzymotec Reports Third Quarter 2015 Results 11/11/2015 10:34:21 AM
Enzymotec To Host A VAYA Pharma Analyst And Investor Day In New York City On November 19, 2015 11/10/2015 10:57:49 AM
Retrospective Analysis Of The Effects Of Enzymotec's Vayarin Showed Significant Improvement Of Emotional Status And Sleep Quality In ADHD Patients With Sleep Disturbances 11/9/2015 8:11:55 AM
Enzymotec To Report Third Quarter 2015 Financial Results 10/29/2015 10:26:29 AM
Enzymotec Granted A New U.S. Patent For Vayacog In Pre-Dementia 10/28/2015 7:17:30 AM
Enzymotec Granted U.S. Patent For INFAT To Promote Intestinal Development And Maturation 8/19/2015 7:12:27 AM
Enzymotec Reports Second Quarter 2015 Results 8/12/2015 12:59:10 PM
Enzymotec Announces The Appointment Of Tamar Howson To Its Board Of Directors 7/30/2015 7:03:47 AM
Enzymotec To Report Second Quarter 2015 Financial Results 7/29/2015 8:50:37 AM
Enzymotec Announces Investigator Initiated Clinical Trial Of Vayarin In Managing ADHD In Children With Epilepsy 7/7/2015 6:59:54 AM